機能ゲノミクス市場：製品・サービス、技術、用途、エンドユーザー別-2025-2030年の世界予測

機能ゲノミクス市場は2023年に161億9,000万米ドルと評価され、2024年には183億米ドルに達すると予測され、CAGR 13.96％で成長し、2030年には404億2,000万米ドルになると予測されています。

機能ゲノミクスは、ゲノミクスの一分野であり、生物学的システム内での遺伝子の機能と相互作用の理解に焦点を当てています。遺伝子発現プロファイリングやゲノム編集技術などのアプローチを活用し、遺伝子の変異が細胞機能にどのような影響を与え、疾患にどのように関与しているかを探る。機能ゲノミクスの必要性は、個別化医療、創薬、疾病診断の進歩における極めて重要な役割から浮かび上がってくる。その用途はバイオテクノロジー、製薬、農業など様々な分野に及び、標的治療薬の開発や、収量や耐性を向上させる遺伝子組み換え作物の開発を可能にしています。この市場の最終用途には、学術研究機関、臨床研究所、バイオテクノロジー企業などが含まれ、革新的なソリューションのために高度なゲノムの洞察を活用することを目指しています。

市場の成長は、次世代シーケンシングやCRISPR-Cas9などの技術的進歩や、新たな治療アプローチを必要とする慢性疾患の有病率の増加が後押ししています。さらに、ゲノム研究に対する政府や民間の資金援助が技術革新を促進し、学界と産業界の協力がトランスレーショナルリサーチを促進します。最近では、人工知能と機械学習を統合して複雑なゲノムデータセットを解析することで、予測モデリングを強化し、創薬プロセスを加速する機会が生まれています。こうした機会を捉えるために、企業は高度なデータ解析プラットフォームに投資し、分野横断的な共同研究を促進すべきです。

しかし、この市場は、高額な装置コスト、複雑なデータ管理要件、遺伝子データの利用と操作をめぐる倫理的懸念などの課題に直面しています。さらに、規制上のハードルやデータ・プライバシーの問題は、機能ゲノミクス技術のシームレスな採用を妨げる可能性があります。精密遺伝子編集、合成生物学、データ解析を効率化するバイオインフォマティクス・ツールなどの分野では、イノベーションが花開く可能性があります。ゲノムデータ解釈のためのユーザーフレンドリーなプラットフォームの開発を模索することで、多様な分野へのアクセスと有用性が広がる可能性があります。市場力学はダイナミックであり、研究技術や分析能力の絶え間ないブレークスルーにより急速に進化しているため、競争優位性を維持するためには継続的な適応と戦略的先見性が必要となります。

市場力学：急速に進化する機能ゲノミクス市場の主要市場インサイトを公開

機能ゲノミクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • がん研究および治療への機能ゲノミクス使用の増加
  • 機能的ゲノムプロジェクトの研究開発に対する政府からの支援金
  • ゲノム技術の著しい進歩
• 市場抑制要因
  • 機能ゲノミクス調査のための高価な機器、試薬、リソースの必要性
• 市場機会
  • 個別化医薬品に対する顧客の嗜好の世界の高まり
  • 機能的ゲノム・ソリューションに対する有利な承認シナリオ
• 市場の課題
  • 倫理・規制上の課題

ポーターのファイブフォース：機能ゲノミクス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：機能ゲノミクス市場における外部からの影響の把握

外部マクロ環境要因は、機能ゲノミクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析機能ゲノミクス市場における競合情勢の把握

機能ゲノミクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス機能ゲノミクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、機能ゲノミクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨機能ゲノミクス市場における成功への道筋を描く

機能ゲノミクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がん調査と治療における機能ゲノミクスの利用増加
    • 機能ゲノムプロジェクトの研究開発に対する政府の支援資金
    • ゲノム技術の大きな進歩
  • 抑制要因
    • 機能ゲノミクス調査のための高価な機器、試薬、リソースの必要性
  • 機会
    • 世界中でパーソナライズ医薬品に対する顧客の嗜好が増加
    • 機能ゲノムソリューションの承認シナリオは良好
  • 課題
    • 倫理的および規制上の課題に関する問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 機能ゲノミクス市場：製品・サービス別

• 消耗品
• サービス
• システムとソフトウェア

第7章 機能ゲノミクス市場：技術別

• マイクロアレイ
• 次世代シーケンシング
• 核酸抽出と精製
• ポリメラーゼ連鎖反応（PCR）

第8章 機能ゲノミクス市場：用途別

• 診断
• 医薬品の発見と開発

第9章 機能ゲノミクス市場：エンドユーザー別

• 病院・クリニック
• 製薬・バイオテクノロジー企業
• 研究センターと学術

第10章 南北アメリカの機能ゲノミクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の機能ゲノミクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの機能ゲノミクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 10x Genomics, Inc.
• Agilent Technologies, Inc.
• AstraZeneca plc
• Bio-Rad Laboratories, Inc.
• Biomatters Limited
• Bionano Genomics, Inc.
• C2i Genomics
• Congenica Ltd.
• Danaher Corporation
• Eagle Genomics
• Eppendorf SE
• Eurofins Scientific SE
• F. Hoffmann-La Roche AG
• Fabric Genomics, Inc.
• Merck & Co., Inc.
• Myriad Genetics, Inc.
• Nest Health Tech Inc.
• Novogene Co., Ltd.
• Oxford Nanopore Technologies PLC
• Pacific Biosciences of California, Inc.
• Personalis, Inc.
• QIAGEN N.V.
• Quest Diagnostics Incorporated
• Rapid Genomics by LGC Biosearch Technologies
• Thermo Fisher Scientific Inc.
• Vizgen, Inc.

LIST OF FIGURES

• FIGURE 1. FUNCTIONAL GENOMICS MARKET RESEARCH PROCESS
• FIGURE 2. FUNCTIONAL GENOMICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. FUNCTIONAL GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. FUNCTIONAL GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. FUNCTIONAL GENOMICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. FUNCTIONAL GENOMICS MARKET DYNAMICS
• TABLE 7. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY SYSTEMS & SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY NUCLEIC ACID EXTRACTION & PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. CANADA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. CANADA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 59. CHINA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. CHINA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. CHINA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. INDIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 63. INDIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. INDIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. INDIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ITALY FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 132. ITALY FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. ITALY FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. ITALY FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. POLAND FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 148. POLAND FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. POLAND FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. POLAND FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. QATAR FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 152. QATAR FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. QATAR FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. QATAR FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. FUNCTIONAL GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 192. FUNCTIONAL GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

The Functional Genomics Market was valued at USD 16.19 billion in 2023, expected to reach USD 18.30 billion in 2024, and is projected to grow at a CAGR of 13.96%, to USD 40.42 billion by 2030.

Functional genomics is a branch of genomics focused on understanding gene functions and interactions within a biological system. It explores how genetic mutations impact cellular functions and contribute to diseases, utilizing approaches such as gene expression profiling and genome editing technologies. The necessity of functional genomics emerges from its pivotal role in advancing personalized medicine, drug discovery, and disease diagnostics. Its application spans various sectors, including biotechnology, pharmaceuticals, and agricultural industries, enabling the development of targeted therapies and genetically engineered crops for improved yield and resistance. The market's end-use scope includes academic research institutions, clinical laboratories, and biotech companies, aiming to leverage advanced genomic insights for innovative solutions.

Market growth is propelled by technological advancements, such as next-generation sequencing and CRISPR-Cas9, and the increasing prevalence of chronic diseases that necessitate novel therapeutic approaches. Additionally, government and private funding for genomic research fosters innovation, while collaborations between academia and industry expedite translational research. Recent opportunities arise in the integration of artificial intelligence and machine learning to analyze complex genomic data sets, thereby enhancing predictive modeling and accelerating drug discovery processes. To seize these opportunities, companies should invest in advanced data analytics platforms and foster cross-disciplinary collaborations.

However, the market faces challenges including high instrumentation costs, complex data management requirements, and ethical concerns surrounding genetic data usage and manipulation. Moreover, regulatory hurdles and data privacy issues could impede the seamless adoption of functional genomics technologies. Innovation can flourish in areas such as precision gene editing, synthetic biology, and bioinformatics tools that streamline data analysis. Exploring the development of user-friendly platforms for genomic data interpretation could broaden access and utility across diverse sectors. The nature of the functional genomics market is dynamic, rapidly evolving with continual breakthroughs in research techniques and analytics capabilities, which necessitates ongoing adaptation and strategic foresight to maintain competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Functional Genomics Market

The Functional Genomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing use of functional genomics for cancer research and treatment
  • Supportive government funding for R&D in functional genome projects
  • Significant advancements in genomic technologies
• Market Restraints
  • Need of expensive equipment, reagents and resources for functional genomics research
• Market Opportunities
  • Growing customer preference for personalized medicines worldwide
  • Favorable approval scenario for functional genomic solutions
• Market Challenges
  • Issues pertaining to ethical and regulatory challenges

Porter's Five Forces: A Strategic Tool for Navigating the Functional Genomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Functional Genomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Functional Genomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Functional Genomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Functional Genomics Market

A detailed market share analysis in the Functional Genomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Functional Genomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Functional Genomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Functional Genomics Market

A strategic analysis of the Functional Genomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Functional Genomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., AstraZeneca plc, Bio-Rad Laboratories, Inc., Biomatters Limited, Bionano Genomics, Inc., C2i Genomics, Congenica Ltd., Danaher Corporation, Eagle Genomics, Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fabric Genomics, Inc., Merck & Co., Inc., Myriad Genetics, Inc., Nest Health Tech Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Personalis, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Rapid Genomics by LGC Biosearch Technologies, Thermo Fisher Scientific Inc., and Vizgen, Inc..

Market Segmentation & Coverage

This research report categorizes the Functional Genomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Service, market is studied across Consumables, Services, and Systems & Software.
• Based on Technology, market is studied across Microarray, Next-Generation Sequencing, Nucleic Acid Extraction & Purification, and Polymerase Chain Reaction (PCR).
• Based on Application, market is studied across Diagnostics and Drug Discovery & Development.
• Based on End-User, market is studied across Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Centers & Academic.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing use of functional genomics for cancer research and treatment
    • 5.1.1.2. Supportive government funding for R&D in functional genome projects
    • 5.1.1.3. Significant advancements in genomic technologies
  • 5.1.2. Restraints
    • 5.1.2.1. Need of expensive equipment, reagents and resources for functional genomics research
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing customer preference for personalized medicines worldwide
    • 5.1.3.2. Favorable approval scenario for functional genomic solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Issues pertaining to ethical and regulatory challenges
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Functional Genomics Market, by Product & Service

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Services
• 6.4. Systems & Software

7. Functional Genomics Market, by Technology

• 7.1. Introduction
• 7.2. Microarray
• 7.3. Next-Generation Sequencing
• 7.4. Nucleic Acid Extraction & Purification
• 7.5. Polymerase Chain Reaction (PCR)

8. Functional Genomics Market, by Application

• 8.1. Introduction
• 8.2. Diagnostics
• 8.3. Drug Discovery & Development

9. Functional Genomics Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals & Clinics
• 9.3. Pharmaceutical & Biotechnology Companies
• 9.4. Research Centers & Academic

10. Americas Functional Genomics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Functional Genomics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Functional Genomics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. Agilent Technologies, Inc.
• 3. AstraZeneca plc
• 4. Bio-Rad Laboratories, Inc.
• 5. Biomatters Limited
• 6. Bionano Genomics, Inc.
• 7. C2i Genomics
• 8. Congenica Ltd.
• 9. Danaher Corporation
• 10. Eagle Genomics
• 11. Eppendorf SE
• 12. Eurofins Scientific SE
• 13. F. Hoffmann-La Roche AG
• 14. Fabric Genomics, Inc.
• 15. Merck & Co., Inc.
• 16. Myriad Genetics, Inc.
• 17. Nest Health Tech Inc.
• 18. Novogene Co., Ltd.
• 19. Oxford Nanopore Technologies PLC
• 20. Pacific Biosciences of California, Inc.
• 21. Personalis, Inc.
• 22. QIAGEN N.V.
• 23. Quest Diagnostics Incorporated
• 24. Rapid Genomics by LGC Biosearch Technologies
• 25. Thermo Fisher Scientific Inc.
• 26. Vizgen, Inc.